Comparison of echinocandin antifungals

Por Eschenauer, Gregory, DePestel, Daryl D, Carver, Peggy L
Publicado em 2007

Evaluating the Impact of Long-Term Outpatient Ertapenem (ETP) vs. Ceftriaxone (CTX) on Clinical Success and Development of Resistance for Documented Enterobacteriaceae Infections

Por Carver, Peggy, Michael, Craig, Facchini, Victoria, Koseck, Anna, Edge, Corey, Nagel, Jerod
Publicado no Open Forum Infect Dis (2017)

Impact of mecA Gene Testing and Intervention by Infectious Disease Clinical Pharmacists on Time to Optimal Antimicrobial Therapy for Staphylococcus aureus Bacteremia at a Universit...

Por Carver, Peggy L., Lin, Shu-Wen, DePestel, Daryl D., Newton, Duane W.
Publicado em 2008

Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study

Por Eschenauer, Gregory A., Carver, Peggy L., Lin, Shu-Wen, Klinker, Kenneth P., Chen, Yee-Chun, Potoski, Brian A., Shields, Ryan K., Clancy, Cornelius J., Nguyen, Minh-Hong, Lam, Simon W.
Publicado em 2013

Real-World Experience with Echinocandin MICs against Candida Species in a Multicenter Study of Hospitals That Routinely Perform Susceptibility Testing of Bloodstream Isolates

Por Eschenauer, Gregory A., Nguyen, M. Hong, Shoham, Shmuel, Vazquez, Jose A., Morris, Arthur J., Pasculle, William A., Kubin, Christine J., Klinker, Kenneth P., Carver, Peggy L., Hanson, Kimberly E., Chen, Sharon, Lam, Simon W., Potoski, Brian A., Clarke, Lloyd G., Shields, Ryan K., Clancy, Cornelius J.
Publicado em 2014